Search

Journal: Current Rheumatology Reviews
Volume: 6 Issue: 3 Year: 2010 Page: 180-183
Author(s): Doris I. Stenver

Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors

Journal: Current Drug Safety
Volume: 5 Issue: 1 Year: 2010 Page: 73-78
Author(s): Guillermo Alberto Keller, Guillermo Di Girolamo

Safety of the Thrombopoiesis-Stimulating Agents for the Treatment of Immune Thrombocytopenia

Journal: Current Drug Safety
Volume: 5 Issue: 2 Year: 2010 Page: 171-181
Author(s): Adam Cuker, Elaine Y. Chiang, Douglas B. Cines

Introduction from Editor-in-Chief

Journal: Current Rheumatology Reviews
Volume: 6 Issue: 3 Year: 2010 Page: 160-161
Author(s): Swamy Venuturupalli

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 8 Issue: 1 Year: 2010 Page: 1-3
Author(s): S. Sardas

QT Interval Prolongation: Preclinical and Clinical Testing Arrhythmogenesis in Drugs and Regulatory Implications

Journal: Current Drug Safety
Volume: 5 Issue: 1 Year: 2010 Page: 54-57
Author(s): Mariano A. Giorgi, Ricardo Bolanos, Claudio Daniel Gonzalez, Guillermo Di Girolamo

Editorial [Hot Topic: Nephrogenic Systemic Fibrosis (Guest Editor: Richard Bucala)]

Journal: Current Rheumatology Reviews
Volume: 6 Issue: 3 Year: 2010 Page: 162-162
Author(s): Richard Bucala

Endocrine Therapies and QTc Prolongation

Journal: Current Drug Safety
Volume: 5 Issue: 1 Year: 2010 Page: 79-84
Author(s): Claudio Daniel Gonzalez, Martha de Sereday, Isaac Sinay, Silvina Santoro

The Spectrum of Nimesulide-Induced-Hepatotoxicity. An Overview

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 9 Issue: 4 Year: 2010 Page: 355-365
Author(s): Fernando Bessone, Luis Colombato, Eduardo Fassio, Maria Virginia Reggiardo, Julio Vorobioff, Hugo Tanno

Editorial [Hot Topic: When Can a Drug be Declared “Safe”? (Guest Editors: Frank M.C. Besag & Seetal Dodd)]

Journal: Current Drug Safety
Volume: 5 Issue: 2 Year: 2010 Page: 112-113
Author(s): Frank M.C. Besag, Seetal Dodd